First Mercantile Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Mercantile Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$147K	Buy	1,340 +92	+7%	+$9.55K	0.02%	529
2021 Q2	$117K	Sell	1,248 -194	-13%	-$17.9K	0.01%	641
2021 Q1	$133K	Sell	1,442 -337	-19%	-$28.4K	0.02%	592
2020 Q4	$130K	Sell	1,779 -339	-16%	-$25.2K	0.01%	605
2020 Q3	$151K	Sell	2,118 -103	-5%	-$7.09K	0.02%	523
2020 Q2	$123K	Sell	2,221 -8,259	-79%	-$353K	0.02%	580
2020 Q1	$310K	Buy	10,480 +234	+2%	+$7.92K	0.05%	232
2019 Q4	$371K	Sell	10,246 -551	-5%	-$16.9K	0.04%	280
2019 Q3	$294K	Sell	10,797 -6	-0.1%	-$155	0.03%	366
2019 Q2	$260K	Buy	10,803 +2,597	+32%	+$65.9K	0.03%	361
2019 Q1	$217K	Buy	+8,206	New	+$194K	0.05%	422
2017 Q2	–	Sell	-11,770	Closed	-$174K	–	878
2017 Q1	$174K	Buy	11,770 +310	+3%	+$5.02K	0.03%	616
2016 Q4	$185K	Buy	+11,460	New	+$208K	0.03%	601
2015 Q2	–	Sell	-646	Closed	-$17K	–	1103
2015 Q1	$17K	Sell	646 -24	-4%	-$440	﹤0.01%	1034
2014 Q4	$9K	Buy	670 +118	+21%	+$1.48K	﹤0.01%	1056
2014 Q3	$7K	Buy	+552	New	+$6.42K	﹤0.01%	1109

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Mercantile Trust's HZNP Position: Q3 2021 in Review

First Mercantile Trust increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 7.4% in Q3 2021, buying an estimated $9.55K and bringing the position to 1,340 shares worth $147K. The position accounts for 0.02% of the portfolio, ranked #529.

First Mercantile Trust first reported a position in HZNP in Q3 2014 and has held it in 16 quarters since. The position peaked at $371K in Q4 2019. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

First Mercantile Trust held 1,340 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $147K as of Q3 2021.
First Mercantile Trust bought 92 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $9.55K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #529 holding.
First Mercantile Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and has held it in 16 quarters since.
First Mercantile Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $371K in Q4 2019.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.